| scholarly article | Q13442814 |
| P2093 | author name string | Yahav J | |
| Melzer E | |||
| Malnick SD | |||
| Attali M | |||
| Duek G | |||
| P2860 | cites work | Eradication of Helicobacter pylori for non-ulcer dyspepsia | Q24245012 |
| An African origin for the intimate association between humans and Helicobacter pylori | Q24671467 | ||
| Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report | Q28264077 | ||
| Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration | Q29547429 | ||
| The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial | Q30677538 | ||
| The role of Helicobacter pylori infection in hematological disorders | Q33406602 | ||
| Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? | Q33484552 | ||
| Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial | Q34013156 | ||
| Recent developments in the epidemiology of Helicobacter pylori | Q34059121 | ||
| Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts | Q34340678 | ||
| The prevalence of Helicobacter pylori infection in different countries. | Q34370026 | ||
| Transmission of Helicobacter pylori: faecal-oral versus oral-oral route. | Q34370031 | ||
| Transmission and epidemiology of Helicobacter pylori. | Q34381727 | ||
| Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population | Q34550966 | ||
| Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii | Q34598713 | ||
| Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review | Q34605352 | ||
| Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study | Q73977756 | ||
| Demographic variations in the rising incidence of esophageal adenocarcinoma in white males | Q74373937 | ||
| Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology | Q77709302 | ||
| "Reappearance" of Helicobacter pylori after eradication: implications on duodenal ulcer recurrence: a prospective 6 year study | Q77894093 | ||
| Inverse associations of Helicobacter pylori with asthma and allergy | Q80201603 | ||
| The changing trends of the incidence of gastric cancer after Helicobacter pylori eradication in Shandong area | Q80938037 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| American Gastroenterological Association medical position statement: evaluation of dyspepsia | Q81476194 | ||
| Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels | Q84244504 | ||
| A National Study of Helicobactor pylori Infection in Gastric Biopsy Specimens | Q84780988 | ||
| Long term follow up of patients treated for Helicobacter pylori infection. | Q34619683 | ||
| American College of Gastroenterology guideline on the management of Helicobacter pylori infection | Q34645482 | ||
| Helicobacter pylori colonization is inversely associated with childhood asthma | Q34791821 | ||
| The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model | Q35112530 | ||
| Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis | Q35872061 | ||
| Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence | Q36018522 | ||
| Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age. | Q36598458 | ||
| Low prevalence of Helicobacter pylori infection in Canadian children: a cross-sectional analysis. | Q37140200 | ||
| Barrett's Esophagus and esophageal adenocarcinoma | Q37265518 | ||
| Coadaptation of Helicobacter pylori and humans: ancient history, modern implications | Q37328454 | ||
| Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort study | Q37684322 | ||
| Effect of Helicobacter pylori infection on symptoms of gastroenteritis due to enteropathogenic Escherichia coli in adults | Q37734790 | ||
| Clinical practice. Helicobacter pylori infection | Q37739073 | ||
| The effect of infectious burden on the prevalence of atopy and respiratory allergies in Iceland, Estonia, and Sweden | Q37859553 | ||
| Human microbiome in health and disease | Q37930658 | ||
| Helicobacter pylori infection: selected aspects in clinical management | Q38150163 | ||
| Helicobacter pylori eradication in functional dyspepsia: HEROES trial. | Q38480411 | ||
| Role of seroconversion in confirming cure of Helicobacter pylori infection | Q39472337 | ||
| Cost-benefit analysis of Helicobacter pylori screening. | Q40489257 | ||
| Helicobacter pylori, gastric ulcer, and agents noxious to the gastric mucosa | Q40884476 | ||
| The incidence of Helicobacter pylori infection | Q40938579 | ||
| Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials | Q41018165 | ||
| The time to eradicate gastric cancer is now | Q41824540 | ||
| Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life | Q42048575 | ||
| Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up | Q43618390 | ||
| Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer | Q43788249 | ||
| Changing patterns in the incidence of esophageal and gastric carcinoma in the United States | Q43873434 | ||
| Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial | Q44727161 | ||
| Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer. | Q44752685 | ||
| Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma | Q44824307 | ||
| Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. | Q50088937 | ||
| Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. | Q50498913 | ||
| Helicobacter pylori stool antigen test: clinical evaluation and cost analysis of a new enzyme immunoassay. | Q50757140 | ||
| Prevalence and determinants of Helicobacter pylori infection in preschool children: a population-based study from Germany. | Q50892998 | ||
| Helicobacter pyloriInfection | Q56157319 | ||
| Inverse Relationship between Gastric Colonization ofHelicobacter pyloriand Diarrheal Illnesses in Children: Results of a Population‐Based Cross‐Sectional Study | Q57192754 | ||
| Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma | Q58204833 | ||
| Helicobacter pylori Eradication for Functional Dyspepsia: What Are We Treating? | Q61536173 | ||
| 'Blooming' in the gut: how dysbiosis might contribute to pathogen evolution | Q63968591 | ||
| NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease | Q72003444 | ||
| An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group | Q72219632 | ||
| An investigation into factors associated with Helicobacter pylori infection | Q73576253 | ||
| Helicobacter pylori--is it a novel causative agent in Vitamin B12 deficiency? | Q73787902 | ||
| P433 | issue | 27 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Helicobacter pylori | Q180556 |
| Helicobacter pylori infectious disease | Q4497153 | ||
| P304 | page(s) | 8979-85 | |
| P577 | publication date | 2014-07-21 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Helicobacter pylori: friend or foe? | |
| P478 | volume | 20 |
| Q34273038 | Association between Helicobacter pylori genotypes and severity of chronic gastritis, peptic ulcer disease and gastric mucosal interleukin-8 levels: Evidence from a study in the Middle East |
| Q35109499 | Association between Virulence Factors and TRAF1/4-1BB/Bcl-xL Expression in Gastric Mucosa Infected with Helicobacter pylori |
| Q26738441 | Fermented Foods: Are They Tasty Medicines for Helicobacter pylori Associated Peptic Ulcer and Gastric Cancer? |
| Q38807634 | Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. |
| Q28073410 | Metabolic Interaction of Helicobacter pylori Infection and Gut Microbiota |
| Q26801329 | Microbiology and ecology are vitally important to premedical curricula |
| Q36326147 | Micronutrients: A double-edged sword in microbial-induced gastric carcinogenesis |
| Q37092643 | The Gastric Mucosa from Patients Infected with CagA+ or VacA+ Helicobacter pylori Has a Lower Level of Dual Oxidase-2 Expression than Uninfected or Infected with CagA-/VacA- H. pylori |
Search more.